首页 >
法规速递
-
国家药监局关于发布仿制药参比制剂目录（第九十二批）的通告（2025年第20号）-2025/5/13
2025-05-14查看详情 > -
Page: How we work-2025/6/19
2025-06-20查看详情 > -
Document: Guidelines on good pharmacovigilance practices (GVP): Introductory cover note, last updated with new Addendum II to Module VI on masking of personal data in individual case safety reports submitted to EudraVigilance-2025/7/24
2025-07-25查看详情 > -
Document: Agenda of the COMP meeting 9-11 September 2025-2025/9/9
2025-09-10查看详情 > -
Document: Respiporc Flu3 : EPAR - Scientific Discussion-2025/10/14
2025-10-15查看详情 > -
Document: EMA health threats plan-2025/11/18
2025-11-19查看详情 > -
Document: Questions and answers on the Union list of critical medicines-2025/12/12
2025-12-15查看详情 > -
鼓励药物研发创新 提升审评审批质效——新条例助推医药产业新发展-2026/1/27
2026-01-28查看详情 > -
Document: Records of data processing activity for the handling the contribution towards commuting costs-2026/3/4
2026-03-05查看详情 > -
Document: European Medicines Agency’s data protection notice for the exchange of information during the Critical Medicines Vulnerability Assessment exercise-2026/4/1
2026-04-02查看详情 >
